Company: ACBM
Filing Date: 2025-07-24
Form Type: 10-K
Source: 0001640334-25-001300
Chunk: 437

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-24
Form: 10-K
Item: Item 7
Chunk 437
---
  $52,233    December 31,  December 31,   2024  2023 Operating lease liabilities      Current portion $26,898  $25,335 Non-current portion  -   26,898 Total $26,898  $52,233 

 F-13Table of Contents

The present value of future lease payments was measured using an incremental borrowing rate of 6.00% per annum as of December 31, 2024 and 2023. Future minimum lease payments under operating leases at December 31, 2024 were as follows: 2025 $27,780 Thereafter  - Total  27,780 Less Imputed interest  (882)Operating lease liabilities $26,898  The Company recognized total lease expense of $27,780 and $26,280 for the years ended December 31, 2024 and 2023, respectively.

NOTE 8 - SUBSEQUENT EVENTS The Company has evaluated subsequent events that have occurred after the date of the balance sheet through the date of issuance of these financial statements and determined that no subsequent event requires recognition or disclosure to the financial statements.

 F-14